1. The splicing factor QKI inhibits metastasis by modulating alternative splicing of E-Syt2 in papillary thyroid carcinoma.
- Author
-
Zhao M, Jin Y, Yan Z, He C, You W, Zhu Z, Wang R, Chen Y, Luo J, Zhang Y, and Yao Y
- Subjects
- Humans, Animals, Cell Line, Tumor, Gene Expression Regulation, Neoplastic, Cell Proliferation, Mice, Female, Male, Ubiquitin Thiolesterase genetics, Ubiquitin Thiolesterase metabolism, Mice, Nude, Cell Movement, Neoplasm Metastasis, RNA, Long Noncoding genetics, RNA, Long Noncoding metabolism, Ubiquitination, Alternative Splicing, RNA-Binding Proteins genetics, RNA-Binding Proteins metabolism, Thyroid Cancer, Papillary genetics, Thyroid Cancer, Papillary pathology, Thyroid Cancer, Papillary metabolism, Thyroid Neoplasms genetics, Thyroid Neoplasms pathology, Thyroid Neoplasms metabolism
- Abstract
Alternative splicing (AS) plays a crucial role in the hallmarks of cancer and can open new avenues for targeted therapies. However, the aberrant AS events and the metastatic cascade in papillary thyroid carcinoma (PTC) remain largely unclear. Here, we identify the splicing factor, quaking protein (QKI), which was significantly downregulated in PTC and correlated with poor survival outcomes in patients with PTC. Functional studies indicated that low expression of QKI promoted the PTC cell growth and metastasis in vitro and in vivo. Mechanistically, low QKI induced exon 14 retention of extended synaptotagmin 2 (E-Syt2) and produced a long isoform transcript (termed E-Syt2L) that acted as an important oncogenic factor of PTC metastasis. Notably, overexpression of long non-coding RNA eosinophil granule ontogeny transcript (EGOT) physically binds to QKI and suppressed its activity by inhibiting ubiquitin specific peptidase 25 (USP25) mediated deubiquitination and subsequent degradation of QKI. Collectively, these data demonstrate the novel mechanistic links between the splicing factor QKI and splicing event in PTC metastasis and support the potential utility of targeting splicing events as a therapeutic strategy for PTC., Competing Interests: Declaration of competing interest The authors declared no competing interests. All authors have seen and approved the manuscript and consent publication., (Copyright © 2024. Published by Elsevier B.V.)
- Published
- 2024
- Full Text
- View/download PDF